Identification and characterization of RAC1-related immune and prognostic subtypes of hepatocellular carcinoma.

This study sheds light on the molecular intricacies of RAC1 in HCC and identifies patient populations that may benefit from immunotherapeutic interventions, with potential implications for tailored treatment strategies.